Education, EUGLOH, Research
SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy
… are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called … events Education EUGLOH Research 02/24/2025 05/05/2025 Formation - training Formation - education EUGLOH Recherche - Research Réservé à …Published on: Thu 20/02/2025 - 15:07